Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Belinsky

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Genes, Chromosomes & Cancer|October 31, 2012
Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumorsMartin G Belinsky, Lori Rink, Douglas B Flieder, et al.
Experimental Dermatology|September 12, 2007
Targeted ablation of Abcc1 or Abcc3 in Abcc6(-/-) mice does not modify the ectopic mineralization processQiaoli Li, Qiujie Jiang, Jennifer Larusso, et al.
BMC Cancer|November 12, 2015
Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST caseMartin G Belinsky, Lori Rink, Kathy Q Cai, et al.
Cell Cycle (Georgetown, Tex.)|September 27, 2008
The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumorsMartin G Belinsky, Lori Rink, Kathy Q Cai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2016
Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic Effects in Preclinical Study of Gastrointestinal Stromal TumorPhillip Zook, Harsh B Pathak, Martin G Belinsky, et al.
Cancer Research|April 16, 1998
Amplification of the ATP-binding cassette 2 transporter gene is functionally linked with enhanced efflux of estramustine in ovarian carcinoma cellsN M Laing, M G Belinsky, G D Kruh, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 22, 2006
Evaluation of the role of multidrug resistance-associated protein (Mrp) 3 and Mrp4 in hepatic basolateral excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in Abcc3-/- and Abcc4-/- miceMaciej J Zamek-Gliszczynski, Ken-ichi Nezasa, Xianbin Tian, et al.
Cancer Research|July 23, 2003
Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transportZhe-Sheng Chen, Robert W Robey, Martin G Belinsky, et al.
Cancer Research|January 11, 2007
Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue-induced damageMartin G Belinsky, Ping Guo, Kun Lee, et al.
Molecular Cancer Therapeutics|August 13, 2009
Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumorLori Rink, Yuliya Skorobogatko, Andrew V Kossenkov, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Genes, Chromosomes & Cancer|October 31, 2012
Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumorsMartin G Belinsky, Lori Rink, Douglas B Flieder, et al.
Experimental Dermatology|September 12, 2007
Targeted ablation of Abcc1 or Abcc3 in Abcc6(-/-) mice does not modify the ectopic mineralization processQiaoli Li, Qiujie Jiang, Jennifer Larusso, et al.
BMC Cancer|November 12, 2015
Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST caseMartin G Belinsky, Lori Rink, Kathy Q Cai, et al.
Cell Cycle (Georgetown, Tex.)|September 27, 2008
The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumorsMartin G Belinsky, Lori Rink, Kathy Q Cai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2016
Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic Effects in Preclinical Study of Gastrointestinal Stromal TumorPhillip Zook, Harsh B Pathak, Martin G Belinsky, et al.
Cancer Research|April 16, 1998
Amplification of the ATP-binding cassette 2 transporter gene is functionally linked with enhanced efflux of estramustine in ovarian carcinoma cellsN M Laing, M G Belinsky, G D Kruh, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 22, 2006
Evaluation of the role of multidrug resistance-associated protein (Mrp) 3 and Mrp4 in hepatic basolateral excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in Abcc3-/- and Abcc4-/- miceMaciej J Zamek-Gliszczynski, Ken-ichi Nezasa, Xianbin Tian, et al.
Cancer Research|July 23, 2003
Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transportZhe-Sheng Chen, Robert W Robey, Martin G Belinsky, et al.
Cancer Research|January 11, 2007
Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue-induced damageMartin G Belinsky, Ping Guo, Kun Lee, et al.
Molecular Cancer Therapeutics|August 13, 2009
Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumorLori Rink, Yuliya Skorobogatko, Andrew V Kossenkov, et al.
Pageof 5